Revolutionizing Healthcare with Early Disease Detection
Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
British officials and space scientists said Tuesday they were disappointed but not deterred after the first attempt to launch satellites into orbit from the U.K. ended in failure.
The small coastal town of Montecito, California -- home to celebrities like Oprah Winfrey, Prince Harry and Meghan Markle and Rob Lowe -- has been evacuated as a result of extensive flooding in the area and surrounding canyons after more than eight inches of rain fell in just 12 hours on Monday.
Virgin Orbit's "Cosmic Girl," a retrofitted Boeing 747 plane, is scheduled for a horizontal launch into orbit Monday night from the United Kingdom's Spaceport Cornwall.
